ClinicalTrials.govpublic full text
Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CML
leukemia,myeloid, chronic, chronic myeloid leukemia, gut, microbiota, tyrosine kinase inhibitors, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810689
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.